Free Access
Vet. Res.
Volume 35, Number 6, November-December 2004
Page(s) 651 - 659
How to cite this article Vet. Res. (2004) 651-659
References of Vet. Res. 35 651-659
  1. Alsemgeest S.P.M., Kalsbeek H.C., Wensing T., Koeman J.P., van Ederen A.M., Gruys E., Concentrations of serum amyloid A (SAA) and haptoglobin (Hp) as parameters of inflammatory diseases in cattle, Vet. Q. 16 (1994) 21-23 [PubMed].
  2. Alsemgeest S.P.M., van't Klooster G.A.E., van Miert A.S.J.P.A.M., Huslkamp-Koch C.K., Gruys E., Primary bovine hepatocytes in the study of cytokine induced acute-phase protein secretion in vitro, Vet. Immunol. Immunopathol. 53 (1996) 179-184 [PubMed].
  3. Blum J.W., Dosogne H., Hoeben D., Vangroenweghe F., Hammon H.M., Burckmaier R.M., Burvenich C., Tumor necrosis factor-$\alpha$ and nitrite/nitrate responses during acute mastitis induced by Escherichia coli infection and endotoxin in dairy cows, Domest. Anim. Endocrinol. 19 (2000) 223-235 [CrossRef] [PubMed].
  4. Burvenich C., Van Merris V., Mehrzad J., Diez-Fraile A., Duchateu L., Severity of E. coli mastitis is mainly determined by cow factors, Vet. Res. 34 (2003) 521-564 [EDP Sciences] [CrossRef] [PubMed].
  5. Eckersall P.D., Young F.J., McComb C., Hogarth C.J., Safi S., Wber A., McDonald T., Nolan A.M., Fitzpatrick J.L., Acute phase proteins in serum and milk from dairy cows with clinical mastitis, Vet. Rec. 148 (2001) 35-41 [PubMed].
  6. Ellis J.A., Godson D., Campos M., Sileghem M., Babiuk L.A., Capture immunoassay for ruminant tumor necrosis factor-alpha: comparison with bioassay, Vet. Immunol. Immunopathol. 35 (1993) 289-300 [PubMed].
  7. Hill A.W., Shears A.L., Hibbit K.G., The pathogenesis of experimental Escherichia coli mastitis in newly calved dairy cows, Res. Vet. Sci. 26 (1979) 97-101 [PubMed].
  8. Hirvonen J., Eklund K., Teppo A.M., Huszenicza G., Kulcsar M., Saloniemi H., Pyörälä S., Acute phase response in dairy cows with experimentally induced Escherichia coli mastitis, Acta Vet. Scand. 40 (1999) 35-46 [PubMed].
  9. Hisaeda K., Hagiwara K., Eguchi J., Yamanaka H., Kirisawa R., Iwai H., Interferon-$\gamma$ and tumor necrosis factor-$\alpha$ levels in sera and whey of cattle with naturally occurring coliform mastitis, J. Vet. Med. Sci. 63 (2001) 1009-1011 [CrossRef] [PubMed].
  10. Hoeben D., Burvenich C., Trevisi E., Bertoni G., Hamann J., Bruckmaier R.M., Blum J.W., Role of endotoxin and TNF-alpha in the pathogenesis of experimentally induced coliform mastitis in periparturient cows, J. Dairy Res. 67 (2000) 503-514 [CrossRef] [PubMed].
  11. Horadagoda N.U., Knox K.M.G., Gibbs H.A., Reid S.W.J., Horadagoda A., Edwards S.E.R., Eckersall P.D., Acute phase proteins in cattle: discrimination between acute and chronic inflammation, Vet. Rec. 144 (1999) 437-441 [PubMed].
  12. Jensen L.E., Whitehead A.S., Regulation of serum amyloid A protein expression during the acute-phase response, Biochem. 334 (1998) 498-503.
  13. Karreman H.J., Wentink G.H., Wensing T., Using serum amyloid A to screen dairy cows for subclinical inflammation, Vet. Q. 22 (2000) 175-178 [PubMed].
  14. Kushibiki S., Hodate K., Shingu H., Obara Y., Touno E., Shinoda M., Yokomizo Y., Metabolic and lactational responses during recombinant bovine tumor necrosis factor-$\alpha$ treatment in lactating cows, J. Dairy Sci. 86 (2003) 819-827 [PubMed].
  15. Lee J., Paape M.J., Elsasser T., Zhao X., Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli, Infect. Immun. 71 (2003) 4034-4039.
  16. Lehtolainen T., Suominen S., Kutila T., Pyörälä S., Effect of intramammary Escherichia coli endotoxin in early- vs. late lactation, J. Dairy Sci. 86 (2003) 2327-2333 [PubMed].
  17. McDonald T.L., Larson M.A., Mack D.R., Weber A., Elevated extrahepatic expression and secretion of mammary-associated serum amyloid A 3 (M-SAA3) into colostrums, Vet. Immunol. Immunopathol. 83 (2001) 203-211 [PubMed].
  18. Menzies F.D., McBride S.H., McDowell S.W.J., McCoy M.A., McConnell W., Bell C., Clinical and laboratory findings in cases of toxic mastitis in cows in Northern Ireland, Vet. Rec. 147 (2000) 123-128 [PubMed].
  19. Nakajima Y., Mikami O., Yoshioka M., Motoi Y., Ito T., Ishikawa Y., Fuse M., Nakano K., Yasukawa K., Elevated levels of tumor necrosis factor-$\alpha$ (TNF-$\alpha$) and interleukin-6 (IL-6) activities in the sera and milk of cows with naturally occuring coliform mastitis, Res. Vet. Sci. 62 (1997) 297-298 [CrossRef] [PubMed].
  20. Ohtsuka H., Kudo K., Mori K., Nagai F., Hatsugaya A., Tajima M., Tamura K., Hoshi F., Koiwa M., Kawamura S., Acute phase response in naturally occurring coliform mastitis, J. Vet. Med. Sci. 63 (2001) 675-678 [CrossRef] [PubMed].
  21. Olson N.C., Hellyer P.W., Dodam J.R., Mediators and vascular effects in response to endotoxin, Br. Vet. J. 151 (1995) 489-515 [PubMed].
  22. Paape M.J., Rautiainen P.M., Lilius E.M., Malstrom C.E., Elsasser T.H., Development of anti-bovine TNF-$\alpha$ mAb and ELISA for quantitating TNF-$\alpha$ in milk after intramammary injection of endotoxin, J. Dairy Sci. 85 (2002) 765-773 [PubMed].
  23. Persson Waller K., Colditz I.G., Lun S., Östensson K., Cytokines in mammary lymph and milk during LPS-induced bovine mastitis, Res. Vet. Sci. 74 (2003) 31-36 [PubMed].
  24. Pyörälä S., Indicators of inflammation in the diagnosis of mastitis, Vet. Res. 34 (2003) 565-578 [EDP Sciences] [CrossRef] [PubMed].
  25. Pyörälä S., Pyörälä E., Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995), J. Am. Vet. Med. Assoc. 212 (1998) 407-412 [PubMed].
  26. Pyörälä S., Kaartinen L., Käck H., Rainio V., Efficacy of two therapy regimes for treatment of experimentally induced Escherichia coli mastitis in the bovine, J. Dairy Sci. 77 (1994) 453-461 [PubMed].
  27. Shuster D.E., Kehrli M.E., Stevens M.G., Cytokine production during endotoxin-induced mastitis in lactating dairy cows, Am. J. Vet. Res. 54 (1993) 80-85 [PubMed].
  28. Sordillo L.M., Peel J.E., Effect of interferon-$\gamma$ on the production of tumour necrosis factor during acute Escherichia coli mastitis, J. Dairy Sci. 75 (1992) 2119-2125 [PubMed].
  29. Sordillo L.M., Pighetti G.M., Davis M.R., Enhanced production of bovine tumor necrosis factor-alpha during the periparturient period, Vet. Immunol. Immunopathol. 49 (1995) 263-270 [PubMed].
  30. Uhlar C.M., Whitehead A.S., Serum amyloid A, the major vertebrate acute-phase reactant, Eur. J. Biochem. 265 (1999) 501-523 [CrossRef] [PubMed].
  31. Urieli-Shoval S., Linke R.P., Matzner Y., Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states, Curr. Opin. Hematol. 7 (2000) 64-69 [CrossRef] [PubMed].
  32. Van Miert A.S.J.P.A.M., Pro-inflammatory cytokines in a ruminant model: pathophysiological, pharmacological, and therapeutic aspects, Vet. Q. 17 (1995) 41-50 [PubMed].
  33. Watanabe A., Yagi Y., Shiono H., Yokomizo Y., Effect of intramammary infusion of tumor necrosis factor-$\alpha$ on milk protein composition and induction of acute phase protein in the lactating cow, J. Vet. Med. B 47 (2000) 653-662 [CrossRef].
  34. Wang Y., Zarlenga D.S., Paape M.J., Dahl G.E., Tomita G.M., Functional analysis of recombinant bovine CD14, Vet. Res. 34 (2003) 413-421 [EDP Sciences] [CrossRef] [PubMed].
  35. Wenz J.R., Barrington G.M., Garry F.B., Dinsmore R.P., Callan R.J., Use of systemic disease signs to assess disease severity in dairy cows with acute coliform mastitis, J. Am. Vet. Med. Assoc. 4 (2001) 567-572.